Works matching DE "OVERACTIVE bladder"
Results: 2887
OVER ACTIVE BLADDER (OAB).
- Published in:
- World Council of Enterostomal Therapists Journal, 2018, v. 38, n. 2, p. 46
- By:
- Publication type:
- Article
Tibial nerve stimulator is safe, effective, and durable, 12-month data indicate: 26.1% of patients with overactive bladder reported continence at 12 months.
- Published in:
- Urology Times, 2021, v. 49, n. 8, p. 10
- By:
- Publication type:
- Article
Study finds opportunity for using subsensory amplitude settings with SNM.
- Published in:
- Urology Times, 2021, v. 49, n. 6, p. 43
- By:
- Publication type:
- Article
Treating a man with benign prostatic disease requires complex decision-making.
- Published in:
- Urology Times, 2021, v. 49, n. 6, p. 12
- By:
- Publication type:
- Article
UroPipeline. FDA authorizes study exploring novel device for bladder incontinence.
- Published in:
- Urology Times, 2021, v. 49, n. 6, p. 10
- By:
- Publication type:
- Article
eCoin neurostimulator is effective in managing overactive bladder, data show.
- Published in:
- Urology Times, 2021, v. 49, n. 5, p. 33
- By:
- Publication type:
- Article
Efficacy and safety of rechargeable SNM device remain high at 2 years.
- Published in:
- Urology Times, 2021, v. 49, n. 3, p. 28
- Publication type:
- Article
Add-on vibegron is effective for OAB in men receiving standard BPH treatments: Investigators also identify independent factors affecting the efficacy of vibegro.
- Published in:
- Urology Times, 2021, v. 49, n. 3, p. 28
- By:
- Publication type:
- Article
Anticholinergic use for 3 months or longer raises dementia risk by about 46%.
- Published in:
- Urology Times, 2021, v. 49, n. 2, p. 32
- By:
- Publication type:
- Article
Mirabegron may improve erectile dysfunction in men with OAB symptoms.
- Published in:
- Urology Times, 2021, v. 49, n. 2, p. 31
- By:
- Publication type:
- Article
PARP inhibitors for prostate cancer take center stage.
- Published in:
- Urology Times, 2021, v. 49, n. 2, p. 6
- By:
- Publication type:
- Article
Mirabegron add-on is safe for OAB in men taking tamsulosin for BPH.
- Published in:
- Urology Times, 2021, v. 49, n. 1, p. 26
- By:
- Publication type:
- Article
UroPipeline/UPDATES ON DRUGS, DEVICES, AND TESTS.
- Published in:
- Urology Times, 2021, v. 49, n. 1, p. 5
- By:
- Publication type:
- Article
Urology in 2020. PARP inhibitors make clinical splash as COVID-19's impact is felt throughout specialty.
- Published in:
- Urology Times, 2020, v. 48, n. 12, p. 1
- By:
- Publication type:
- Article
UPDATES ON DRUGS, DEVICES, AND TESTS.
- Published in:
- Urology Times, 2020, v. 48, n. 11, p. 8
- By:
- Publication type:
- Article
Smoking associated with increased incidence of overactive bladder.
- Published in:
- Urology Times, 2020, v. 48, n. 10, p. 10
- By:
- Publication type:
- Article
Three-week test phase improves odds of success for sacral neuromodulation.
- Published in:
- Urology Times, 2020, v. 48, n. 10, p. 9
- By:
- Publication type:
- Article
Preoperative bladder symptom score best predictor of mesh surgery success.
- Published in:
- Urology Times, 2020, v. 48, n. 10, p. 9
- By:
- Publication type:
- Article
Nocturia: How do you define it, and how do you treat it?
- Published in:
- 2020
- By:
- Publication type:
- Interview
Overactive bladder treatment maintains favorable long-term safety profile.
- Published in:
- Urology Times, 2020, v. 48, n. 9, p. 8
- By:
- Publication type:
- Article
Overactive bladder: Another agent attempts a step forward.
- Published in:
- Urology Times, 2020, v. 48, n. 9, p. 8
- By:
- Publication type:
- Article
Wearable neuromodulation device shows promise for overactive bladder: Feasibility study results indicate nonimplanted, intravaginal device is safe and comfortable.
- Published in:
- Urology Times, 2020, v. 48, n. 8, p. 28
- By:
- Publication type:
- Article
American Urological Association meeting moves from Washington to the web.
- Published in:
- Urology Times, 2020, v. 48, n. 7, p. 32
- Publication type:
- Article
HERO data impress as FDA grants relugolix priority review.
- Published in:
- Urology Times, 2020, v. 48, n. 7, p. 6
- By:
- Publication type:
- Article
Study adds to evidence linking anticholinergics and dementia: Dementia more prevalent in patients taking anticholinergic vs beta-3 agonist, data indicate.
- Published in:
- Urology Times, 2020, v. 48, n. 5, p. 36
- By:
- Publication type:
- Article
New developments may change treatment of OAB: β-agonist, PTNS devices may soon offer more options for improving QoL.
- Published in:
- Urology Times, 2020, v. 48, n. 4, p. 36
- By:
- Publication type:
- Article
How do gender differences affect incontinence management? Urologists must differentiate between bladder outlet obstruction and pure OAB in male patients.
- Published in:
- 2020
- Publication type:
- Question & Answer
FDA ACCEPTS NEW DRUG APPLICATION FOR OVERACTIVE BLADDER AGENT.
- Published in:
- Urology Times, 2020, v. 48, n. 3, p. 7
- Publication type:
- Article
Trial supports combined behavioral, medical approach to treating OAB.
- Published in:
- Urology Times, 2020, v. 48, n. 2, p. 28
- By:
- Publication type:
- Article
RECHARGEABLE SNM SYSTEM EARNS FDA APPROVAL FOR OAB, RETENTION.
- Published in:
- Urology Times, 2019, v. 47, n. 12, p. 12
- Publication type:
- Article
Selective bladder denervation found efficacious in refractory OAB: Objective, subjective improvements observed regardless of detrusor overactivity status.
- Published in:
- Urology Times, 2019, v. 47, n. 12, p. 12
- By:
- Publication type:
- Article
Final rule, State of Specialty mark end of 2019 and what lies ahead.
- Published in:
- Urology Times, 2019, v. 47, n. 12, p. 8
- By:
- Publication type:
- Article
Tibial stimulation device demonstrates sustained OAB symptom relief: Statistically significant health-related quality of life improvement seen through 36-month follow-up.
- Published in:
- Urology Times, 2019, v. 47, n. 11, p. 14
- By:
- Publication type:
- Article
OAB treatment efficacy similar in frail, nonfrail patients: 2nd-, 3rd-line treatments feasible in appropriately selected frail adults.
- Published in:
- Urology Times, 2019, v. 47, n. 11, p. 13
- By:
- Publication type:
- Article
Combination therapy addressed in amended OAB guideline.
- Published in:
- 2019
- By:
- Publication type:
- Interview
Model highlights cost savings of single-stage SNM.
- Published in:
- Urology Times, 2019, v. 47, n. 10, p. 11
- By:
- Publication type:
- Article
OVERACTIVE BLADDER TX NOT LINKED TO CV EVENTS.
- Published in:
- Urology Times, 2019, v. 47, n. 8, p. 13
- Publication type:
- Article
UroPipeline / DRUGS, DEVICES, AND TESTS IN DEVELOPMENT.
- Published in:
- Urology Times, 2019, v. 47, n. 6, p. 31
- Publication type:
- Article
Twelve Part D urology meds top $100 million in spending: Prostate cancer, overactive bladder drugs at head of list.
- Published in:
- Urology Times, 2019, v. 47, n. 6, p. 20
- By:
- Publication type:
- Article
OAB device produces durable efficacy through 12 months.
- Published in:
- Urology Times, 2019, v. 47, n. 5, p. 10
- By:
- Publication type:
- Article
Phase III trial to evaluate OAB Tx in men on BPH treatment.
- Published in:
- Urology Times, 2019, v. 47, n. 4, p. 36
- Publication type:
- Article
Overactive bladder agent meets primary endpoint in phase IIb study.
- Published in:
- Urology Times, 2019, v. 47, n. 4, p. 36
- Publication type:
- Article
UroPipeline / DRUGS, DEVICES, AND TESTS IN DEVELOPMENT.
- Published in:
- Urology Times, 2019, v. 47, n. 2, p. 36
- Publication type:
- Article
More than 50% of patients stop botulinum treatment: Treatment discontinuation seen despite improvement after two injections.
- Published in:
- Urology Times, 2018, v. 46, n. 11, p. 10
- By:
- Publication type:
- Article
Rechargeable neuromodulation system found efficacious: Clinically significant reductions in OAB symptoms seen at 1-year follow-up.
- Published in:
- Urology Times, 2018, v. 46, n. 11, p. 10
- By:
- Publication type:
- Article
OAB patients continue medical therapy unnecessarily: Sacral neuromodulation monotherapy efficacious as third-line treatment.
- Published in:
- Urology Times, 2018, v. 46, n. 11, p. 8
- By:
- Publication type:
- Article
PELVIC FLOOR EXERCISES HELP WITH DETRUSOR OVERACTIVITY.
- Published in:
- Urology Times, 2018, v. 46, n. 11, p. 7
- Publication type:
- Article
UroPipeline.
- Published in:
- Urology Times, 2018, v. 46, n. 10, p. 48
- Publication type:
- Article
Ablation of trigone shows promise in treating OAB: No long-term adverse events observed, data show.
- Published in:
- Urology Times, 2018, v. 46, n. 10, p. 12
- By:
- Publication type:
- Article
Study: OnabotulinumtoxinA injections found safe in elderly patients.
- Published in:
- Urology Times, 2018, v. 46, n. 10, p. 12
- By:
- Publication type:
- Article